Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This book is aimed at pharmaceutical fraternity involving as students, researchers, teachers, regulators, policy makers to understand key aspects of intellectual property matters. The book is planned for quick understanding of basic concepts leading to practice in pharmaceutical Industry. The book provides clear cut understanding of national and international scenario of IPR matters.
Conventional English was used instead of legal language for the sake of initiators in learning IPR matters in pharmaceuticals.
Major emphasis is relating to pharmaceuticals.
History of IPR matters at global and national levels
International Conventions on IPR matters only relating to pharmaceuticals
Objective and role of GATT, WTO and TRIPS agreement.
How to do literature search relating to non-patented and patented information for innovation and patent mining.
Administration structure, protocol to become a member of WTO and procedure to resolve disputes.
Various disputes settled at WTO of India relating to pharmaceuticals.
Judgments, case studies, notices relating to pre-grant opposition, post-grant opposition, compulsory licensing, infringements, working of patents, revoke of patents.
Above 100 frequently asked questions relating to Patents, Regulatory and Marketing relating to pharmaceuticals.
Statistics relating to patent grants at IPO, USPTO, and DMFs at USFDA relating to India
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.
This book is aimed at pharmaceutical fraternity involving as students, researchers, teachers, regulators, policy makers to understand key aspects of intellectual property matters. The book is planned for quick understanding of basic concepts leading to practice in pharmaceutical Industry. The book provides clear cut understanding of national and international scenario of IPR matters.
Conventional English was used instead of legal language for the sake of initiators in learning IPR matters in pharmaceuticals.
Major emphasis is relating to pharmaceuticals.
History of IPR matters at global and national levels
International Conventions on IPR matters only relating to pharmaceuticals
Objective and role of GATT, WTO and TRIPS agreement.
How to do literature search relating to non-patented and patented information for innovation and patent mining.
Administration structure, protocol to become a member of WTO and procedure to resolve disputes.
Various disputes settled at WTO of India relating to pharmaceuticals.
Judgments, case studies, notices relating to pre-grant opposition, post-grant opposition, compulsory licensing, infringements, working of patents, revoke of patents.
Above 100 frequently asked questions relating to Patents, Regulatory and Marketing relating to pharmaceuticals.
Statistics relating to patent grants at IPO, USPTO, and DMFs at USFDA relating to India